Butylscopolamine

Butylscopolamine

SCHEMBL29643439

CCCC[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 7/20 1.00
CHRM1 P11229 5/20 1.00
BLM P54132 4/20 1.00
TSHR P16473 4/20 1.00
PMP22 Q01453 2/20 1.00
CYP2D6 P10635 1/20 1.00
KCNH2 Q12809 1/20 1.00
LMNA P02545 2/20 0.98
CHRM5 P08912 5/20 0.76
CHRM4 P08173 3/20 0.75
CHRM3 P20309 3/20 0.75
HIF1A Q16665 2/20 0.75
CYP3A4 P08684 1/20 0.75
CYP2C9 P11712 1/20 0.75
HSD17B10 Q99714 1/20 0.75
SMN1; SMN2 Q16637 1/20 0.68
CYP1A2 P05177 1/20 0.61
NFKB1 P19838 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butylscopolamine SCHEMBL2446872 1.00 CHRM2 (1.00) CHRM2CHRM1BLMTSHRPMP22
Butylscopolamine SCHEMBL2446869 1.00 CHRM2 (1.00) CHRM2CHRM1BLMTSHRPMP22
Butylscopolamine SCHEMBL29473416 1.00 CHRM2 (1.00) CHRM2CHRM1BLMTSHRPMP22
Butylscopolamine SCHEMBL14672547 1.00 CHRM2 (1.00) CHRM2CHRM1BLMTSHRPMP22
Butylscopolamine SCHEMBL155102 1.00 CHRM2 (1.00) CHRM2CHRM1BLMTSHRPMP22
Butylscopolamine SCHEMBL16168163 1.00 CHRM2 (1.00) CHRM2CHRM1BLMTSHRPMP22
Butylscopolamine SCHEMBL25292 0.99 BLM (1.00) CHRM2CHRM1BLMTSHRPMP22
Butylscopolamine SCHEMBL25291 0.99 BLM (1.00) CHRM2CHRM1BLMTSHRPMP22
Butylscopolamine SCHEMBL2441812 0.99 BLM (1.00) CHRM2CHRM1BLMTSHRPMP22
Butylscopolamine SCHEMBL10732357 0.99 CHRM2 (0.98) CHRM2CHRM1BLMTSHRPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4154879-B1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NICOTINE WITHDRAWAL SYMPTOMS KOREA INST SCI & TECH (KR) 2025-09-10 EP claimed
EP-4213862-A1 IMPROVED PHARMACEUTICAL PREPARATION CytoPharma Ltd. (GB) 2023-07-26 EP disclosed
EP-2938328-B1 MONOLITHIC PHARMACEUTICAL FORM FOR MODIFIED RELEASE OF AN ACTIVE INGREDIENT COMBINATION HENNIG ARZNEIMITTEL GMBH&CO KG (DE) 2023-07-05 EP disclosed
EP-4126920-A2 GIF RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF Takeda Pharmaceutical Company Limited (JP) 2023-02-08 EP disclosed
WO-2022211996-A1 LIPOPHILIC ACTIVE AGENT INFUSED TOBACCO LEAVES AND/OR TOBACCO MATERIALS AND METHODS OF USE THEREOF Poviva Corp. (US) 2022-10-06 WO disclosed
WO-2022058203-A1 IMPROVED PHARMACEUTICAL PREPARATION CYTOPHARMA GMBH (DE) 2022-03-24 WO disclosed